Literature DB >> 25791834

Reclaiming the name 'bronchiectasis'.

James D Chalmers1, J Stuart Elborn2.   

Abstract

Entities:  

Keywords:  Bronchiectasis; Cystic Fibrosis; Respiratory Infection

Mesh：

Year:  2015        PMID： 25791834     DOI： 10.1136/thoraxjnl-2015-206956

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  10 in total

1.  Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research Registry.

Authors:  Ashwin Basavaraj; Radmila Choate; Doreen Addrizzo-Harris; Timothy R Aksamit; Alan Barker; Charles L Daley; M Leigh Anne Daniels; Edward Eden; Angela DiMango; Kevin Fennelly; David E Griffith; Margaret M Johnson; Michael R Knowles; Mark L Metersky; Peadar G Noone; Anne E O'Donnell; Kenneth N Olivier; Matthias A Salathe; Andreas Schmid; Byron Thomashow; Gregory Tino; Kevin L Winthrop
Journal:  Chest       Date:  2020-07-03       Impact factor: 9.410

2.  Effects of Pulmonary Rehabilitation on Systemic Inflammation and Exercise Capacity in Bronchiectasis: A Randomized Controlled Trial.

Authors:  Amanda Souza Araújo; Mara Rúbia Figueiredo; Isabella Lomonaco; Fernando Lundgren; Rafael Mesquita; Eanes Delgado Barros Pereira
Journal:  Lung       Date:  2022-05-11       Impact factor: 2.584

3.  Exercise training for bronchiectasis.

Authors:  Annemarie L Lee; Carla S Gordon; Christian R Osadnik
Journal:  Cochrane Database Syst Rev       Date:  2021-04-06

Review 4.  Global impact of bronchiectasis and cystic fibrosis.

Authors:  Margarida Redondo; Holly Keyt; Raja Dhar; James D Chalmers
Journal:  Breathe (Sheff)       Date:  2016-09

Review 5.  Raising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults.

Authors:  James D Chalmers; Sanjay Sethi
Journal:  NPJ Prim Care Respir Med       Date:  2017-03-13       Impact factor: 2.871

Review 6.  Bacterial Community Interactions During Chronic Respiratory Disease.

Authors:  Allison L Welp; Jennifer M Bomberger
Journal:  Front Cell Infect Microbiol       Date:  2020-05-14       Impact factor: 5.293

7.  A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial.

Authors:  Judy Martina Bradley; Rohan Anand; Brenda O'Neill; Kathryn Ferguson; Mike Clarke; Mary Carroll; James Chalmers; Anthony De Soyza; Jamie Duckers; Adam T Hill; Michael R Loebinger; Fiona Copeland; Evie Gardner; Christina Campbell; Ashley Agus; Alistair McGuire; Roisin Boyle; Fionnuala McKinney; Naomi Dickson; Danny F McAuley; Stuart Elborn
Journal:  Trials       Date:  2019-12-19       Impact factor: 2.279

Review 8.  The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration.

Authors:  James D Chalmers; Megan Crichton; Pieter C Goeminne; Michael R Loebinger; Charles Haworth; Marta Almagro; Montse Vendrell; Anthony De Soyza; Raja Dhar; Lucy Morgan; Francesco Blasi; Stefano Aliberti; Jeanette Boyd; Eva Polverino
Journal:  Breathe (Sheff)       Date:  2017-09

Review 9.  Patient participation in ERS guidelines and research projects: the EMBARC experience.

Authors:  James D Chalmers; Alan Timothy; Eva Polverino; Marta Almagro; Thomas Ruddy; Pippa Powell; Jeanette Boyd
Journal:  Breathe (Sheff)       Date:  2017-09

Review 10.  [Management of Primary Ciliary Dyskinesia].

Authors:  J Raidt; J Brillault; F Brinkmann; A Jung; C Koerner-Rettberg; A Koitschev; H Linz-Keul; T Nüßlein; F C Ringshausen; J Röhmel; M Rosewich; C Werner; H Omran
Journal:  Pneumologie       Date:  2020-09-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.